Posted in | News | Business | Composites | Fibers

Celanese Acquires Long Fiber Reinforced Thermoplastics Business from FACT

Celanese Corporation (NYSE: CE), a leading, global chemical company, today announced the acquisition of the long-fiber reinforced thermoplastics (LFT) business of FACT GmbH (Future Advanced Composites Technology) of Kaiserslautern, Germany, a business unit of The Ravago Group.

"Celanese continues to execute our strategy to build advantaged positions through strategic uses of cash for high-return projects to grow our business where we have sustainable advantages".

Completion of the change of ownership will occur on December 31, 2009. Financial details of the transaction were not disclosed.

FACT is a leading producer of long-fiber reinforced thermoplastics (LFT) used in injection moulding, extrusion, compression moulding and blow moulding applications.

"Celanese continues to execute our strategy to build advantaged positions through strategic uses of cash for high-return projects to grow our business where we have sustainable advantages," said David Weidman, chairman and chief executive officer, Celanese.

The acquisition will support Celanese's Advanced Engineered Materials business segment, specifically Ticona Engineering Polymers, by building upon Ticona's LFT process technology and broadening specific product offerings to improve the capability to grow with its customers through a new production site in Kaiserslautern.

"This acquisition will grow the company's Celstran product line, expand industry coverage, and combine development capabilities of both companies to serve increasingly demanding customer and segment expectations in the automotive industry and in general industrial applications," concluded Roeland Polet, vice president, Ticona.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.